Actavis Inc.
99
0
1
95
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
3.0%
3 terminated/withdrawn out of 99 trials
96.9%
+10.4% vs industry average
31%
31 trials in Phase 3/4
36%
34 of 95 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (99)
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
Role: collaborator
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions
Role: lead
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Role: lead
Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg
Role: lead
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Role: lead
Pancreatic Enzyme Supplementation for Celiac Disease
Role: collaborator
Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension
Role: lead
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
Role: lead
Clinical Equivalence Study of Mometasone Nasal Spray
Role: lead
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
Role: lead
Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults
Role: lead
Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water
Role: lead
Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain
Role: lead
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
Role: lead
A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee
Role: lead
A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris
Role: lead
Clinical Endpoint Study of Ivermectin 1% Cream
Role: lead
A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea
Role: lead
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
Role: lead
Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
Role: lead